PMDA drug package insert
ドプラム注射液400mg
PMDA Prescription drug · キッセイ薬品工業株式会社 · package insert Dec 25, 2024
Key facts
| Brand names | ドプラム注射液400mg |
|---|---|
| Nonproprietary names | ドキサプラム塩酸塩水和物 |
| Companies | 製造販売元／キッセイ薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 呼吸促進剤 |
| Therapeutic category codes | 872219 |
| YJ codes | 2219400A1031 |
| Approval numbers | 21800AMX10307000 |
| Package insert edition | 第2版 |
| Package insert date | Dec 25, 2024 |
| PMDA document key | 230034_2219400A1031_1 |
| PMDA company code | 230034 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: